期刊论文详细信息
OxCD3: Oxford Centre for Drug Delivery Devices 卷:5
Clinical trial protocol for TARDOX: a phase I study to investigate the feasibility of targeted release of lyso-thermosensitive liposomal doxorubicin (ThermoDox®) using focused ultrasound in patients with liver tumours.
Lyon PC
DOI  :  10.1186/s40349-017-0104-0
PMID  :  29118984
【 授权许可】

Unknown   

  文献评价指标  
  下载次数:0次 浏览次数:10次